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Abstract 
 
Objective 
Health-related quality of life (HRQoL) concerns of adolescents and young adults (AYAs) aged 14-25 
years were compared with those of older adults (26-60 years) with cancer.   
Methods 
AYAs and older adults receiving curative intent treatment or supportive palliative care for cancer 
were recruited from eight research centres across Europe. Participants used a rating scale to score 
the relevance and importance of a list of 77 issues covering 10 areas of HRQoL concern: Symptoms; 
activity restrictions; social; emotional; body image; self-appraisals; outlook on life; lifestyle; 
treatment-related and life beyond treatment. 
Results 
HRQoL issues were reviewed by 33 AYAs and 25 older adults. Several issues were recognised as 
relevant and important across all age groups: symptoms, emotional impact, outlook on life, lifestyle 
and treatment-related. A number of issues were more relevant or important to AYAs including 
interrupted education, greater motivation to achieve academic goals, increased maturity, boredom, 
fertility, and change in living situation. 
Conclusion 
While there is overlap in several of the HRQoL concerns across the age span, it is important that 
HRQoL measures used with AYAs capture the diverse and unique psychosocial aspects of this 
developmental stage. 
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Introduction 
Irrespective of a diagnosis of cancer, adolesents and young adults (AYAs) find themselves in a period 
of transition from childhood to adulthood characterised by significant physical and cognitive changes 
as well as critical psychosocial challenges.  Developing a sense of identity, decisions regarding career 
choices, challenges relating to peer relationships, as well as establishing autonomy from family 
members are hallmarks of this development stage (Erikson, 1963).  The development of intimate 
relationships and questions relating to sexuality are also integral features during adolescence and 
early or emerging adulthood.  A diagnosis of cancer during this crucial developmental stage will 
further complicate and disrupt the negotiation of these challenges (Sansom-Daly & Wakefield, 2013; 
Zebrack, 2011). 
While cancer in AYAs is relatively rare, its incidence is increasing and the incidence of cancer in AYAs 
is higher than in children (Bleyer, O’Leary, Barr, & Ries, 2006; Croucher, Whelan, Moller, Davies, 
2009; Stiller et al., 2006; van der Horst, Winther, & Olsen, 2006). In Europe, 14,000 new cases of 
cancer are diagnosed in AYAs annually (Steliarova-Foucher et al., 2015).  AYAs are also more likely to 
be diagnosed with advanced or aggressive cancers (Bleyer et al., 2006). Ten per cent of tumours 
seen in AYAs are predominantly childhood tumours, while 30% of tumours have a peak in 
adolescence and include Hodgkin’s Lymphoma, Ewing’s Sarcoma, osteosarcoma, germ-cell tumours 
and rare soft-tissue sarcomas. A final 60% are early-onset adult cancers (Eden, 2006; Birch et al., 
2002). Furthermore, cancer-specific outcomes in AYAs are significantly worse than in children and 
older adults (Chen et al., 2018; Keegan et al., 2016; Stiller et al., 2006). There is also evidence to 
suggest that current services are not meeting the specific needs of this age group with AYAs often 
finding themselves treated within paediatric or adult settings (Bleyer, 2005; Thomas, Albritton, & 
Ferrari, 2010; Zebrack et al., 2013). 
 
Irrespective of age, a cancer diagnosis is likely to be met with negative emotions such as anxiety and 
uncertainty. However, the emotional impact of cancer has been widely reported to be felt more 
significantly by AYAs with cancer compared with other age groups, especially older adults, with an 
elevated risk of distress, depression and anxiety (Burgoyne et al., 2015; Lang, David, & Giese-Davis, 
2015; Park & Rosenstein, 2015). In addition, symptom side effects such as fatigue, weakness, 
sickness, pain, and difficulty concentrating are also likely to be recognised by all age groups with 
specific symptoms linked more closely to tumour site or treatment type rather than age. However, 
once again, the perception of these might vary according to age with younger adults reporting 
greater symptom burden and cognitive dysfunction as well as expressing greater concerns about 
body image, sexuality, and fertility (Avis, Crawford, & Manuel, 2005).   An investigation into the 
  
effect of age on HRQoL using a pooled analysis of randomised controlled trials which used the EORTC 
QLQ-C30 (Aaronson et al., 1993) revealed poorer social functioning and greater financial difficulties 
amongst younger patients (Quinten et al., 2015) and this has been replicated in lymphoma 
(Oerlemans, Nijziel, & van de Poll‐Franse, 2015) and thyroid patients (Mols et al., 2018).  As 
mentioned above, for AYAs, their diagnosis and treatment is likely to disrupt important personal 
goals such as forging a career pathway or establishing intimate relationships and thus they are likely 
to experience cancer differently compared with other age groups as they see themselves lagging 
behind their peers and where they had hoped to be in life. Snobholm and Heiwe (2013) proposed 
that younger people’s experiences of cancer also differ from those of older cancer patients due to a 
lack of previous experience of severe illness.  Perceptions of HRQoL are shaped by past experience, 
present circumstances, and expectations for the future (Bowling, 2001) and thus age and 
developmental stage are likely to play a role. AYAs will not necessarily be aligned to older adults in 
their appraisals of the HRQoL impact of cancer. 
In an outline of research priorities for AYAs with cancer, the AYA Oncology Progress Review Group 
acknowledged that the research infrastructure for assessing AYA cancer-related issues is inadequate 
and needs to be supported by the development or modification of existing AYA assessment tools 
(Adolescent and Young Adult Oncology Progress Review Group, 2006). Our programme of research, 
carried out on behalf of the EORTC Quality of Life Group (QLG), addresses this key issue by 
investigating the optimal way of assessing the impact of cancer on the health-related quality of life 
(HRQoL) of AYAs. Firstly, we investigated the broad spectrum of HRQoL concerns of 45 AYAs aged 
14-25 years who were currently on treatment or receiving palliative support for cancer (Sodergren et 
al., 2018). Our interviews captured numerous concerns relating to symptoms, restrictions to 
activities, disrupted life plans, body image, self-appraisals, outlook on life, lifestyle, treatment, 
fertility as well as the social, emotional and financial impact on life.  Our current study aims to 
identify whether there are differences according to age in terms of the impact of cancer on different 
areas of HRQoL, specifically whether there are particular concerns which are more relevant and 
important to AYAs.  We have also previously acknowledged that amongst AYAs themselves, there 
might be distinct differences (Sodergren et al., 2018) given that between the ages of 14 and 25, 
significant life changes occur, for example, leaving compulsory education, starting out on a career 
and changes to living arrangements supporting a more independent existence. 
 
To our knowledge, this is the first study to make a direct comparison between AYAs and older adults 
undergoing treatment or supportive care for cancer in terms of the wide spectrum of HRQoL 
  
concerns.  Previous research providing age comparisons (Avis et al., 2005; Burgoyne et al., 2015; 
Lang et al., 2015; Mao et al., 2007) are often limited in their focus to one particular aspect of HRQoL 
or in terms of age range which is not inclusive of adolescents  (Avis et al., 2005; Mao et al., 2007). 
This study provides insight into whether AYAs are unique in terms of the impact of cancer on 
different aspects of HRQoL which in turn will have implications for how HRQoL is assessed in this age 
group.  Specifically, if there are age differences in terms of the impact of cancer, HRQoL measures 
will need to be tailored to the specific concerns of this age group.  The current study addresses the 
following hypotheses: 
1. HRQoL issues which are not developmentally related such as symptoms, emotions, and impact on 
family, will be rated as relevant and important to all cancer patients regardless of age. 
2. AYAs will differ from older adults in terms of how they perceive cancer to impact on their life 
across a number of areas including education and work, socially, fertility. 
3. Although AYAs form a distinct group, there will be some differences between younger and older 
AYAs in their evaluation of how cancer has affected their life. 
Method 
Study design 
The study was designed in accordance with the EORTC QLG module development guidelines 
(Johnson et al., 2011) with the protocol peer reviewed and approved by the EORTC QLG.  As 
mentioned above, the study forms part of a larger study designed to develop a suitable method for 
assessing HRQoL in AYAs and as part of this, age comparisons were performed in order to justify 
whether or not an AYA specific measure is required. To identify whether certain HRQoL concerns are 
more prominent amongst AYAs (14-25 years), we invited AYAs and older adults (26-60 years) to be 
interviewed.  As part of the interview, participants were asked to review the relevance and 
importance of a list of HRQoL issues generated from AYAs aged 14-25 (Sodergren et al., 2018) as well 
as issues captured from a systematic review of the literature on AYA oncology (Sodergren et al., 
2017).  The list included 77 issues organised according to the following categories:  Symptoms 
(physical, cognitive) (n=12 issues); Activity restrictions (including disrupted life plans) (n=7); Social 
(interactions with family and friends) (n=14); Emotional (n=12); Body image (n=3); Self-appraisals 
(how one feels about oneself) (n=7); Outlook on life (including priorities) (n=9); Lifestyle (n=5); 
Treatment-related (including treatment burden) (n=5); and Life beyond treatment (n=5).  
Participants were encouraged to adopt a “think aloud” approach (Ericsson & Simon, 1980) when 
rating the issues and the narratives were recorded for the purposes of providing insight into why the 
  
ratings had been assigned and also to help inform the next phase of research involving the selection 
of issues to be included in an AYA-specific questionnaire. 
 
Participants 
AYAs aged between 14 and 25 years receiving treatment or supportive palliative care for cancer 
were recruited from eight research centres across France, Israel, Norway (two centres), Poland, The 
Netherlands and UK (two centres).  AYAs were recruited and interviewed at hospitals.  Those who 
had completed curative intent treatment and attending a clinic for follow-up only were excluded 
from the study. Older adults with cancer aged 26-60 years were also recruited and represented our 
comparison group.  We adopted a similar approach to the one used in the development of the 
EORTC HRQoL questionnaire specific to elderly patients (EORTC QLQ-ELD15; Johnson et al., 2010) 
which compared ratings of elderly patients to those of younger adults. 
In order to capture any potential differences within the AYA group, we formed two sub-groups: 
younger AYAs (14-18 years) and older AYAs (19-25 years).  The older adults were also sub-divided:  
26-50 years and 51-60 years.  In view of the different distribution of cancer types according to age, 
groups were not matched according to diagnosis. In line with EORTC QLG guidelines (Johnson et al., 
2011), the intention was to recruit 10-15 participants per age sub-group.  
Ethical and research governance approvals were obtained at each centre in accordance with local 
requirements.  Participants and, where appropriate (for participants aged 14 and 15 years), parents 
were given verbal and written information about the study with participation explained as a one off 
interview whereby a list of issues arising from previous interviews with AYAs would be reviewed for 
relevance and importance.  Parents of adolescents below the age of 16 were shown the interview 
schedule before making their decision regarding their child’s participation and were given the option 
to accompany their child during the interview.  Interviews were arranged once consent and, where 
appropriate, assent were given. 
Interviews 
Before the interview started, a case report form was completed together with participants and 
included details relating to education attainment, employment status and domestic situation.  
Participants were also helped to complete a measure of performance status (the Eastern 
Cooperative Oncology Group; ECOG, Oken et al., 1982), which gave a broad indication of the impact 
of disease and treatment on daily activities.  Participants were then invited to review the issue list in 
terms of relevance (whether or not they recognised or experienced an issue using a yes/no response 
  
option) and importance (extent to which an issue had been troublesome or bothersome to them) on 
a 4-point Likert scale ranging from 1 “Not at all” to 4 “Very much”.  Participants were also asked to 
talk about why they had assigned a particular score to issues, i.e., why something is relevant or 
important to them. The interview schedule is available as supplementary material (Supplementary 
material 1).  Following completion of the interview, the researcher accessed medical notes to record 
information relating to diagnosis and treatment schedules.   
Data analysis 
Ratings for each HRQoL concern were analysed in terms of percentage of participants indicating that 
an issue was relevant to them and mean importance score (1-4).  Ratings were compared across the 
four age groups. Tests of significance using the chi squared statistic (for relevance) and ANOVA (for 
importance) were also performed. These tests were treated as indicative rather than confirmatory 
given the increased Type I error risk due to the number of tests carried out and sub-group sample 
sizes. The significance level was consequently adjusted using the Bonferonni correction to p<.0001.  
No official post-hoc statistical comparisons were performed and we have exercised caution in our 
interpretation of the findings given the small sample sizes. Thus, we were largely guided by the 
EORTC QLG recommendations for the interpretation of ratings with relevance of >60% and mean 
importance of >1.5 identified as benchmarks. Analyses were carried out using IBM SPSS Statistics 24.  
Results 
Participant characteristics 
A total of 58 patients were involved in the review process and were recruited from 6 countries.  
Table 1 displays the socio-demographic and clinical characteristics of the participants.  Slightly more 
female patients were interviewed (57%), the sample was predominantly white (88%) with an age 
range of participants between 14-58 years.  The sample included 14 AYAs aged 14-18 years, 19 older 
AYAs aged 19-25 years, 12 adults aged 26-50 years and 13 older adults aged 51-60 years.  
Participants presented 12 different tumour types with a distinction in diagnosis type according to 
age group:  21% of AYAs were diagnosed with leukaemia which was not represented in the other age 
groups.  Lymphoma was the most common diagnosis of 14-18 years, while breast and colorectal 
cancer were only presented by older adults.  Disease status was predominantly localised (48%) with 
the majority of participants (97%) currently on treatment and for 87.5% of those on treatment, it 
was delivered with curative intent. Chemotherapy was the most frequently reported (81%) 
treatment option.  The majority of patients did not report any co-morbidities (71%) and this was 
especially true for younger AYAs.  Older adults predominantly (61.5%) rated themselves as unable to 
carry out work activities. In contrast to the other age groups, the majority of younger AYAs were 
currently enrolled in compulsory education, were not in employment and lived with their parents.  
  
 
Insert Table 1 about here. 
 
HRQoL issues ratings 
Table 2 displays the individual HRQoL issue ratings across the age groups in terms of percentage 
participants in each age group marking an issue as relevant and mean importance rating (1-4 with a 
higher number indicating greater importance). The results of the tests of significance are also 
presented in Table 2. 
 
Insert Table 2 about here. 
Hypothesis 1. Some HRQoL issues will be rated as relevant and important across age groups and are 
thus not unique to AYAs  
Several HRQoL concerns evaluated did not emerge as age-specific in terms of their relevance, with at 
least 60% of participants in each age group identifying with the concern, and mean importance of 
>1.5 for each age group. These generic concerns include symptoms (such as pain, tiredness, energy, 
loss of strength), impact on hobbies and leisure time activities, interrupted life plans (falling behind 
in life), emotional impact (worry about the future, recurrence and dying, shock), body image 
concerns (altered appearance), outlook on life (such as changed priorities), lifestyle and treatment-
related factors (such as difficulty adjusting to being ill and treatment burden). Avoidance of 
infections was also recognised as relevant and important across age groups (mean>1.5 and 
relevance >60%) but particularly high amongst the 14-18 year olds (relevant to all participants of this 
age group and mean 3.2).  A strengthening of relationships with family and friends was recognised as 
an important issue across age groups (mean >2) and, with the exception of older adults, was 
recognised as relevant by at least 60% of participants within each age group (including 93% of 14-18 
year olds). The impact on romantic/intimate relationships was relevant to older AYAs (79%) and 26-
50 year olds (67%).   
In addition, some issues resonated more for older adults (in particular 51-60 years) compared with 
the AYAs and include restrictions in ability to care for others (mean 3.5 compared to 1.3 for 14-18 
year olds) which achieved a significance level of p<.0001 , and financial difficulties which were 
relevant to only 36% (mean importance 1.2) of younger AYAs compared with 77% (mean importance 
3.0) of older adults. 
  
Hypothesis 2. Some issues will be recognised as more relevant and important to AYAs aged 14-25 
years.   
A number of issues were rated as more relevant and important to AYAs. Interruption to education 
was identified as relevant to 86% of 14-18 year olds and 100% of 19-25 year olds compared with 
25% of 26-50 year olds and 15% of 51-60 year olds (p=.001).  AYAs also assigned greater importance 
to the impact of cancer on education with a mean of 3 for 14-18 year olds compared with 1.3 for 51-
60 year olds (p=.004).  Despite facing disruptions to their education, a greater drive to succeed 
academically was recognised as an important issue amongst AYAs with a mean importance rating of 
>2 for both of the AYA age groups compared with 1.3 and 1.2 for 26-50 and 51-60 year olds 
respectively.  This issue was also rated as particularly relevant to the younger AYAs (86% of 14-18 
year olds compared with 8% of 51-60 year olds) and both relevance and importance ratings reached 
the significance threshold (p<.001).   
Increased maturity was also recognised as more relevant and important for AYA with 86% of 14-25 
year olds and 68% 19-25 year olds recognising this issue (mean importance >2 for both groups) 
compared with 25% of 26-50 years and none of the older adults (mean importance 1.4 and 1.0 
respectively).  Differences between groups in terms of increased maturity achieved significance at 
p<.0001. 
Access to age appropriate information was also more important to AYAs (mean of > 1.5 for both AYA 
sub-groups compared with 1.3 and 1.2 for the older age groups respectively, these differences did 
not however reach significance) and was discussed in the context of psychosocial concerns specific 
to the age group, for example fertility concerns, the long term effects of treatment in particular with 
respect to future health as well as prospects for future employment and intimate relationships.  
Fertility concerns were significantly more relevant and important to AYAs (at p<.0001)  with 71% of 
14-18 year olds and 68% of 19-25 year olds identifying these as relevant compared to 50% and 8% of 
the older age groups (26-50 years and 51-60 years respectively). Mean importance was 3.3 for 19-25 
year olds compared to 1.1 for 51-60 year olds. 
Hypothesis 3. The two AYA sub-groups will differ in their ratings of some HRQoL issues  
For the younger AYAs (14-18 year olds), cancer was more likely to be seen as an opportunity to forge 
new friendships (relevant to 86%, mean importance of 2.4) compared to 19-25 year olds (relevant to 
37% and mean importance of 1.7). A greater motivation to achieve personal goals was also 
recognised as more relevant to younger AYAs (79%) compared with the other groups. In addition, for 
this age group, boredom was also more frequently recognised (86%) although there was no 
significant difference across the age groups for these HRQoL concerns.   
  
A change in living situation (e.g., having to move in with parents) was however recognised as more 
relevant (63%) to older AYAs (19-25 years) compared to only 8% of younger AYAs (14-18 year olds).  
Importance ratings also followed a similar pattern with a mean of 2.7 for the older AYAs compared 
with 1.1 for their younger counterparts. Differences in change in living situation across the age 
spectrum did not however reach the threshold for significance (p=.001 for both relevance and 
importance). 
 
Discussion 
Our study compared HRQoL issues facing AYAs aged 14-25 years with cancer with older adults (26-60 
years) with cancer and included evaluations of the extent to which they were troublesome to them. 
Several of the issues describing symptoms, treatment side effects as well as the emotional impact of 
cancer were rated as relevant and important irrespective of age group and thus confirm our 
hypothesis. These issues are generic (non-tumour, treatment or age-specific) and are covered by 
available HRQoL generic cancer instruments (e.g., EORTC QLQ-C30; Aaronson et al., 1993) and thus 
we would not necessarily expect significant age differences.   
 
The AYA literature provides numerous reports of disconnected social networks following a cancer 
diagnosis (Ang et al., 2018; Bansal, Sharma, Vatsa, & Bakhshi, 2013; Momani et al., 2015). The AYAs 
we previously interviewed (Sodergren et al., 2018) talked about their friends not knowing how to 
help them and feeling uncomfortable around them as they did not expect someone of their age to 
become so ill.  In the current study, the social impact of cancer was recognised as relevant and 
important across all age groups including, but not confined to, AYAs.  However, the opportunity for 
new friendships was identified as particularly important and relevant for the younger group of AYAs 
aged 14-18 years suggesting that, at this age, peer relationships take centre stage.  With a larger 
sample size, the differences between groups might have been more pronounced and reached 
significance. 
 
Our findings relating to the impact of cancer on education for AYAs replicate what we previously 
found (Sodergren et al., 2018) as well as other research (Ang, Koh, Lee, Shorey, 2018;  
Chiang, Yeh, Wang, & Yang, 2009; Sandeberg, Johansson, Björk, & Wettergren, 2008) and features in  
measures used with young people such as the PedsQL (Varni, Burwinkle, Katz, Meeske, & Dickinson,  
2002). It was also not surprising that the impact on education was more obvious for younger  
  
participants as they were mostly currently enrolled in education or had to suspend their education  
following their diagnosis.   
 
Boredom was recognised as more common amongst younger AYAs and has been reported in the 
literature on children with cancer (Moody et al., 2006).  It can be speculated that younger people 
tend to lead more active lives which is brought to a sudden halt by a diagnosis of cancer. In addition, 
younger people might be more affected by their peers’ levels of achievement and therefore their 
own life involving hospital visits and stays might seem boring in comparison. Hinds et al. (2004) 
found that when discussing the impact of illness and treatment, adolescents often made reference 
to milestones reached by their peers such as selecting colleges and learning to drive. Regardless of a 
cancer diagnosis, boredom is common amongst adolescents and is regarded as functional for 
psychological growth (Biolcati, Mancini, & Trombini, 2018) therefore expressions of boredom might 
be viewed as a positive issue and a proxy for feeling better and “normal”. 
Lack of age appropriate information was a more salient concern for AYAs and related specifically to 
the psychosocial concerns of this age group which have previously been reported in the context of 
unmet needs (e.g., Zebrack et al., 2013) and in recognition of the importance of the delivery of age 
appropriate care to AYAs (e.g., Marris, Morgan & Stark, 2011). Fertility concerns were also more 
relevant and important to AYAs which echoes previous research with AYAs with calls for fertility to 
be brought to the forefront of AYA measures (Stinson et al., 2015).  
Although the importance of avoiding infections was recognised across age groups, it was more 
relevant and important to younger AYAs (although not significant) compared with older age groups 
and this might be explained by the common cancer diagnoses of the younger age group (leukaemia, 
lymphoma) which are linked to immunosuppression and thus increased risk of infection.   
Issues relating to a relinquishing of autonomy in the form of having to move back home to be cared 
for by parents was more relevant and important to AYAs within the 19-25 year old group.  This is the 
age whereby people are looking to gain independence from parents and having to return to the 
family home is likely to be seen as a backward step.  This issue was not so relevant to the younger 
AYAs who had not yet left the family home.   
 
Previous research with AYAs has tended to look at the impact of cancer through a more negative  
lens in terms of the hindrance of goals (Daniel, Barakat, Brumley, & Schwartz, 2014) and lack of  
motivation (Chiang et al., 2009) although benefit finding amongst adolescents which included  
increased drive to achieve was reported by Wicks & Mitchell (2010).  We found that AYAs  
  
were more likely to identify positive impacts of cancer in the form of increased motivation to  
achieve academic and personal goals as well as greater maturity through the experience of having  
cancer, which has been previously reported in the literature (Enskär, Carlsson, Golsäter, & Hamrin,  
1997; Wicks & Mitchell, 2010). As mentioned earlier, an additional positive outcome recognised by  
more younger AYAs (14-18 years) was cancer opening up the opportunity to meet new friends who 
were going through similar experiences.   
 
Although the younger and older AYAs exhibited some similarities in their HRQoL judgements, there 
were some differences, as noted above, in terms of change in domestic arrangements and impact of 
friendships.  These differences between younger and older AYAs support previous claims that AYAs 
with cancer should not be treated as a homogeneous entity (Treadgold & Kuperberg, 2010). 
Although our definition of AYA is aligned with the UK AYA oncology service provision, this age range 
is broad in terms of the different developmental stages it embraces (Erikson, 1963), with a 14 year 
old likely to live at home with no financial responsibilities and dependent on parents while a 25 year 
old might be more financially independent with responsibilities and have dependents of their own.   
Limitations 
We were guided by the EORTC QLG framework when setting our target sample size but the 
recommendations for this phase of research assume more exploratory work rather than 
confirmatory statistical enquiry.  We conducted statistical analyses to help interpret our findings but 
we acknowledge that the generalisability of the findings and reliability of our conclusions are 
restricted by our small sample. In addition, our conclusions might also be compromised by the 
method in which we performed our comparions – using relevance and importance ratings. The 
extent to which the participants understood the task and accurately conveyed their judgements 
could be questioned.  However, the task was completed in the presence of the researcher who was 
available to answer any questions and clarify the task.  Finally, there might have been some bias in 
terms of how the study was introduced to participants – they were told that the issues had already 
been recognised by AYAs and that we wanted to check whether or not they are unique to this age 
group, thus older participants might have had the expectation that several of the issues would not 
be relevant to them.  However, there was notable overlap between the groups in terms of issues 
which were relevant and important.  Researchers across centres received a briefing (interview script) 
from the coordinator in order to improve rigor and maintain consistency across sites and reduce the 
potential for bias. 
  
Conclusion 
While there is some overlap in the HRQoL impact of cancer on AYAs and older age groups, our study 
highlights the unique and diverse concerns of AYAs, shaped by their current life situation and 
developmental stage.  Our findings not only have implications for how HRQoL is best assessed with 
AYAs but also in terms of other aspects of clinical practice. An understanding of the different ways in 
which a diagnosis and its treatment fits in to a young person’s life might help inform the type of 
conversations clinicians have with them and also in terms of treatment planning in order to minimise 
disruption to the young person’s life. 
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Table 1.  Socio-demographic and clinical characteristics of participants (AYAs and older adults) N=58 
Variable Total 
Interviewed 
(N=58) 
14-18 years 
(n=14) 
19-25 years 
(n=19) 
26-50 years 
(n=12) 
51-60 years 
(n=13) 
     
Patients recruited per 
country  
     
France  4 (6.9%) 0 (0) 4 (21.1%) 0 0 
Israel  2 (3.4%) 2 (14.3%) 0 0 0 
Netherlands  14 (24.1%) 2 (14.3%) 5 (26.3%) 5 (41.7%) 2 (15.4%) 
Norway  6 (10.3%) 3 (21.4%) 0 1 (8.3%) 2 (15.4%) 
Poland  19 (32.8) 2 (14.3%) 5 (26.3%) 4 (33.3%) 8 (61.5%) 
United Kingdom  13 (22.4%) 5 (35.7%) 5 (26.3%) 2 (16.7%) 1 (7.7%) 
Gender      
Male 25 (43.1%) 7 (50.0%) 9 (47.4%) 5 (41.7%) 4 (30.8%) 
Female 33 (56.9%) 7 (50.0%) 10 (52.6%) 7 (58.3%) 9 (69.2%) 
Age (years)      
Mean (standard 
deviation) 
31.5 (15.3) 16.7 (1.4) 21.8 (2.0) 38.4 (7.9) 54.9 (2.5) 
Range 14-58 14-18 19-25 26-49 51-58 
Ethnicity      
White 51 (87.9%) 13 (92.9%) 15 (78.9%) 10 (83.3%) 13 (100%) 
Asian 1 (1.7%) 0 0 1 (8.3%) 0 
Mixed 2 (3.4) 1 (7.1%) 0 1 (8.3%) 0 
Missing 4 (6.9%) 0 4 (21.1%) 0 0 
Education level      
Currently not able to 
complete education 
3 (5.2%) 1 (7.1%) 2 (10.5%) 0 0 
Currently in compulsory 
education 
6 (10.3%) 6 (42.9%) 0 0 0 
Compulsory school 
education completed 
15 (25.9%) 4 (28.6%) 4 (21.1%) 3 (25.0%) 4 (30.8%) 
Post compulsory school 21 (36.2%) 3 (21.4%) 8 (42.1%) 4 (33.3%) 6 (46.2%) 
  
education (college) 
University 13 (22.4%) 0 5 (26.3%) 5 (41.7%) 3 (23.1%) 
Employment status      
Full time 6 (10.3%) 0 3 (15.8%) 2 (16.7%) 1 (7.7%) 
Part time 9 (15.5%) 0 4 (21.1%) 4 (33.3%) 1 (7.7%) 
Homemaker 3 (5.2%) 0 0 1 (8.3%) 2 (15.4%) 
Sick leave 13 (22.4%) 1 (7.1%) 2 (10.5%) 3 (25.0%) 7 (53.8%) 
Disability 2 (3.4%) 0 0 1 (8.3%) 1 (7.7%) 
None 22 (37.9%) 11 (78.6%) 9 (47.4%) 1 (8.3%) 1 (7.7%) 
Other 2 (3.4%) 1 (7.1%) 1 (5.3%) 0 0 
Missing 1 (1.7%) 1 (7.1%) 0 0 0 
Living situation      
Alone 8 (13.8%) 0 4 (21.1%) 2 (16.7%) 2 (15.4%) 
Parents 27 (46.6%) 14 (100%) 10 (52.6%) 2 (16.7%) 1 (7.7%) 
Partner 18 (31.0%) 0 3 (15.8%) 6 (50.0%) 9 (69.2%) 
Living with others 4 (6.9%) 0 1 (5.3%) 2 (16.7%) 1 (7.7%) 
Missing 1 (1.7%) 0 1 (5.3%) 0 0 
Time since diagnosis 
(months) 
     
Median 4 4 2.5 4 5 
Range 0-48 0-37 0-29 1-32 1-48 
Disease status      
Localised  28 (48.3%) 6 (42.9%) 10 (52.6%) 8 (66.7%) 8 (61.5%) 
Metastatic 17 (29.3%) 2 (14.3%) 3 (15.8%) 4 (33.3%) 4 (30.8%) 
Not applicable 
(Leukaemia, lymphoma) 
10 (17.2%) 6 (42.9%) 4 (21.1%) 0 0 
Missing 3 (5.2%) 0 2 (10.5%) 0 1 (7.7%) 
Diagnosis1      
Leukaemia 7 (12.1%) 3 (21.4%) 4 (21.1%) 0 0 
Lymphoma 7 (12.1%) 6 (42.9%) 1 (5.3%) 0 0 
Gynaecological 12 (20.7%) 0 4 (21.1%) 5 (41.7%) 3 (23.1%) 
Testicular 5 (8.6%) 2 (14.3%) 3 (15.8%) 0 0 
Bone 5 (8.6%) 3 (21.4%) 2 (10.5%) 0 0 
  
Sarcoma 4 (6.9%) 0 3 (15.8%) 1 (8.3%) 0 
Head and neck 2 (3.4%) 0 0 1 (8.3%) 1 (7.7%) 
Breast  8 (13.8%) 0 0 3 (25.0%) 5 (38.5%) 
Melanoma 2 (3.4%) 1 (7.1%) 1 (5.3%) 0 0 
Lung 1 (1.7%) 0 0 1 (8.3%) 0 
Colorectal 4 (6.9%) 0 0 0 4 (30.8%) 
Oesophagus 1 (1.7%) 0 0 1 (8.3) 0 
Missing 1 (1.7%) 0 1 (5.3%) 0 0 
Treatment status       
Currently on 
treatment 
56 (96.6%) 13 (92.9%) 18 (94.7%) 12 (100%) 12 (92.3%) 
Supportive / palliative 
care 
2 (3.4%) 1 (7.1%) 0 0 1 (7.7%) 
Missing 0 0 1 (5.3%) 0 0 
Treatment intent      
Curative 49 (84.5%) 14 (100%) 16 (84.2%) 10 (83.3%) 9 (69.2%) 
Palliative 7 (12.1%) 0 2 (10.5%) 1 (8.3%) 4 (30.8%) 
Missing 2 (3.4%) 0 1 (5.3%) 1 (8.3%) 0 
Treatment type2      
Chemotherapy 47 (81.0%) 11 (78.6%) 15 (78.9%) 10 (83.3%) 11 (84.6%) 
Radiotherapy 10 (17.2%) 2 (14.3%) 2 (10.5%) 3 (25%) 3 (23.1%) 
Hormonal 2 (3.4%) 0 0 0 2 (15.4%) 
Targeted therapy 3 (5.2%) 0 2 (10.5%) 1 (8.3%) 0 
Steroid 2 (3.4%) 1 (7.1%) 1 (5.3%) 0 0 
Other (not specified) 3 (5.2%) 0  2 (16.7%) 1 (7.7%) 
Missing 2 (3.4%) 0 1 (5.3%) 0 1 (7.7%) 
Co-morbidities3      
None 41 (70.7%) 14 (100%) 13 (68.4%) 7 (58.3%) 7 (53.8%) 
Renal  1 (1.7%) 0 1 (5.3%) 0 0 
Cardiac 4 (6.9%) 0 1 (5.3%) 0 3 (23.1%) 
Respiratory  4 (6.9%) 0 1 (5.3%) 1 (8.3%) 2 (15.4%) 
Rheumatic  3 (5.2%) 0 1 (5.3%) 2 (16.7%) 0 
Diabetes 1 (1.7%) 0 0 0 1 (7.7%) 
  
Thyroid 1 (1.7%) 0 0 0 1 (7.7%) 
Obesity 1 (1.7%) 0 1 (5.3%)   
Skin problems (e.g., 
psoriasis) 
1 (1.7%) 0 0 0 1 (7.7%) 
Missing 3 (5.2%) 0 2 (10.5%) 1 (8.3%) 0 
ECOG Performance 
Status4 
     
0 (Fully active) 16 (27.6%) 7 (50%) 4 (21.1%) 3 (25%) 2 (15.4%) 
1 (Restricted in physical 
strenuous activity) 
17 (29.3%) 2 (14.3%) 9 (47.4%) 3 (25%) 3 (23.1%) 
2 (Unable to carry out 
work activities) 
18 (31.0%) 4 (28.6%) 4 (21.1%) 2 (16.7%) 8 (61.5%) 
3 (Limited self-care) 1 (1.7%) 0 0 1 (8.3%) 0 
Missing 5 (8.6%) 1 (7.1%) 2 (10.5%) 2 (16.7%) 0 
 
1One participant had more than one diagnosis 
2Patients indicated all current treatment types 
3Several patients presented more than one co-morbidity 
4One participant indicated 0.5 (between fully active and restricted) on the ECOG Performance Status   
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
14-18 years 19-25 years 26-50 years 51-60 years 
Tests of significant 
differences according to 
Age 
HRQoL Issues 
% 
Relevance 
 Mean (SD) 
Importance 
% 
Relevance 
 Mean (SD) 
Importance 
% 
Relevance 
 Mean (SD) 
Importance 
% 
Relevance 
 Mean (SD) 
Importance 
 
Relevance 
 
 
 
Importance  
Symptoms 
Greater 
awareness of 
physical 
symptoms 
79 2.2 (1.1) 74 2.8 (1.03) 92 2.2 (1.9) 77 2.4 (1.3) X
2
 (3, N = 54) 
= 2.38, 
p=.498 
F (3,54) = 1.02, 
p =.393 
Pain 
71 2.2 (1.5) 74 3.2 (0.8) 75 2.5 (1.2) 85 3.2 (1.2) X
2
 (3, N 
= 54) = 
2.75, 
p=.431 
F (3,54) = 
2.67, p 
=.056 
Nausea 
71 2.2 (1.3) 79 3.3 (0.8) 92 3.2 (1.0) 92 3.5 (0.5) X
2
 (3, N 
= 54) = 
6.44 , 
p=.092 
F (3,52) = 
5.22,  
p =.003 
Vomiting 
64 1.8 (1.3) 74 2.9 (0.8) 63 2.5 (1.4) 85 3.1 (0.6) X
2
 (3, N 
= 54) = 
6.09 , 
p=.107 
F (3,53) = 
4.58, 
p=.006 
Tiredness 
100 3.0 (1.0) 79 3.3 (0.7) 100 3.4 (1.0) 100 3.5 (0.5) NA F (3,54) = 
0.93, 
p=.431, 
Lack of energy 
86 2.9 (1.1) 79 3.3 (0.6) 100 3.5 (0.7) 100 3.6 (0.5) X
2
 (3, N = 54) 
= 5.93 , 
p=.115 
F (3,53) = 2.13, 
p=.107, 
 
 
Loss of 86 2.6 (1.0) 74  2.9 (1.0) 83 2.7 (1.2) 100 3.3 (0.5) X
2
 (3, N = 54) F (3,54) = 1.33, 
 Table 2. HRQoL Issues according to age group 
HRQoL Issues % Relevance  Mean (SD) Importance % Relevance  
Mean (SD) Importance % Relevance  Mean (SD) Importance % 
Relevance  Mean (SD) Importance Relevance 
 Importance  
         
 ab 
 
 
 
 
 
 
 
strength = 2.65, 
p=.449 
p=.274 
 
Shortness of 
breath 
57 1.5 (1.1) 53 2.2 (0.8) 58 2.3 (1.3) 85 2.2 (0.9) X
2
 (3, N = 54) 
=2.83, 
p=.418 
F (3,54) = 1.76, 
p=.166 
 
 
Trouble 
sleeping 
64 1.7 (1.4) 68 2.6 (0.7) 100 2.8 (1.3) 92 2.7 (0.9) X
2
 (3, N = 54) 
=7.48, 
p=.058 
F (3,54) = 2.80, 
p=.049 
 
Difficulty 
gaining weight 
29 1.2 (1.2) 47 2.2 (1.3) 58 1.8 (1.4) 46 1.9 (1.3) X
2
 (3, N = 53) 
= 3.49, 
p=.322 
F (3,53) = 1.49, 
p=.227 
Mobility 
problems 
57 1.5 (1.3) 63 2.6 (1.2) 58 1.7 (1.4) 77 2.7 (1.1) X
2
 (3, N = 54) 
=2.76, 
p=.430 
F (3,53) = 3.55, 
p=.020 
Difficulty 
concentrating 
71 1.9 (0.9) 74 2.5 (0.8) 67 2.4 (1.2) 92 3.0 (0.9) X
2
 (3, N = 54) 
= 5.09, 
p=.165 
F (3,54) = 3.15, 
p =.032 
 
Activity 
Restrictions 
Impact on 
hobbies/ 
leisure time 
activities 
93 3.2 (1.1) 74 3.2 (1.1) 83 2.8 (1.3) 92 2.9 (0.8) X
2
 (3, N = 54) 
= 1.02, 
p=.797 
F (3,53) = 0.50, 
p=.684 
 
Not able to 
bathe, take 
showers or 
dress yourself 
64 1.8 (1.3) 58 2.4 (1.0) 42 1.6 (1.2) 77 2.8 (1.2) X
2
 (3, N = 54) 
= 4.13, 
p=.247 
F (3,53) = 2.98, 
p =.040  
 
Not able to go 
out 
71 2.5 (1.6) 74 3.1 (0.7) 58 2.2 (1.5) 69 2.3 (1.2) X
2
 (3, N = 54) 
= 4.66, 
F (3,52) = 1.47, 
p=.233 
 
 
 
 
 
 
 
p=.199  
Education has 
been 
interrupted 
86 3.0 (1.4) 100 2.6 (1.6) 25 1.5 (1.3) 15 1.2 (1.1) X
2
 (3, N = 54) 
= 16.92,         
p =.001 
F (3,53) = 5.02, 
p=.004 
Changed career 
plans 
57 1.8 (1.6) 58 2.5 (1.2) 58 2.3 (1.6) 62 2.5 (1.5) X
2
 (3, N = 54) 
= 1.02, 
p=.797 
F (3,53) = 0.71, 
p=.548 
 
Not able to 
work 
71 2.2 (1.4) 68 2.9 (1.1) 83 2.6 (1.4) 92 3.9 (0.3) X
2
 (3, N = 54) 
= 2.30, 
p=.512 
F (3,52) = 5.59, 
p =.002 
 
Fallen behind 
where you 
want to be in 
life 
64 1.9 (1.4) 68 2.9 (1.6) 67 2.0 (1.4) 62 2.5 (1.3) X
2
 (3, N = 54) 
= 2.72, 
p=.436 
F (3,53) = 2.25, 
p=.093 
 
Social 
Loss of friends 
57 1.6 (1.5) 37 2.0 (1.4) 33 1.7 (1.4) 15 1.7 (1.3) X
2
 (3, N = 54) 
= 5.52, 
p=.137 
F (3,53) = 0.23, 
p=.878 
 
Isolation from 
friends 
64 2.1 (1.4) 68 2.5 (1.2) 58 2.7 (1.5) 69 2.6 (1.2) X
2
 (3, N = 54) 
= 3.00, 
p=.391 
F (3,53) = 0.49, 
p=.689 
 
Less time to go 
out with 
friends 
86 2.6 (1.2) 58 2.5 (1.0) 75 2.5 (1.3) 54 1.8 (0.8) X
2
 (3, N = 53) 
= 3.86, 
p=.277 
F (3,52)= 1.62, 
p=.195 
 
Impact on 
romantic/ 
sexual 
relationships 
50 1.6 (1.5) 79 2.8 (0.9) 67 2.6 (1.4) 54 2.8 (1.4) X
2
 (3, N = 54) 
= 10.43,         
p =.015 
F (3,51)= 2.83, 
p =.048 
 
 
 
 
 
 
 
Strengthening 
existing 
relationships 
with friends 
and family 
93 2.8 (0.8) 63 2.7 (1.1) 75 2.3 (1.3) 46 2.3 (1.4) X
2
 (3, N = 54) 
= 8.13           
p =.043 
F (3,51) = 0.75, 
p=.527 
 
Opportunity to 
make new 
friends 
86 2.4 (1.1) 37 1.7 (0.9) 17 1.2 (1.1) 46 1.6 (0.7) X
2
 (3, N = 54) 
= 12.62,        
p =.006 
F (3,52) = 3.31,  
p =.027 
Greater 
dependence on 
others 
71 1.9 (1.3) 74 3.0 (0.7) 50 2.3 (1.5) 85 3.2 (0.8) X
2
 (3, N = 54) 
= 7.59, 
p=.055 
F (3,52) = 4.23, 
p =.009 
 
Greater burden 
on others 
71 2.4 (1.1) 74 3.0 (0.9) 75 2.5 (1.1) 85 3.5 (0.9) X
2
 (3, N = 54) 
= 2.75, 
p=.431 
F (3,52) = 3.37,  
p =.025 
Change in living 
situation  
21 1.1 (1.3) 63 2.7 (1.4) 42 1.8 (1.4) 8 0.9 (0.3) X
2
 (3, N = 53) 
= 17.09,          
p =.001 
 
F (3,52) = 6.93, 
p =.001 
 
Impact on 
family and 
friends 
93 2.6 (1.1) 74 3.2 (0.8) 83 3.2 (1.1) 85 3.8 (0.4) X
2
 (3, N = 53) 
=  9.72, 
p=.808 
F (3,51) = 3.58, 
p =.020 
Impact on 
family life 
93 2.7 (1.1) 68 3.1 (0.7) 75 3.0 (1.1) 92 3.9 (0.3) X
2
 (3, N = 53) 
= 4.07, 
p=.254 
F (3,52) = 4.21, 
p =.010 
 
Unable to care 
for others 
50 1.3 (1.1) 42 2.2 (1.1) 50 1.9 (1.3) 77 3.5 (0.7) X
2
 (3, N = 53) 
= 3.99, 
p=.263 
F (3,52) = 9.15, 
p =<.001 
 
 
 
 
 
 
 
 Less tolerant 
of others 
57 1.6 (1.3) 53 2.1 (1.0) 33 1.5 (1.2) 54 2.1 (1.0) X
2
 (3, N = 53) 
= 3.18, 
p=.365 
F (3,52) = 0.91, 
p=.441 
 
More 
sympathetic to 
others 
79 2.1 (1.2) 42 2.2 (1.1) 17 1.3 (1.0) 62 2.4 (1.1) X
2
 (3, N = 53) 
= 10.93,         
p =.012 
 
F (3,52) = 2.06, 
p=.117 
 
Emotional 
Boredom 
86 2.2 (0.9) 58 2.3 (0.9) 50 1.6 (1.2) 31 1.4 (0.7) X
2
 (3, N = 53) 
= 9.10,          
p =.028 
 
F (3,52) = 3.52, 
p =.021 
 
Depression 
86  2.3 (1.2) 79 2.7 (0.7) 54 2.1 (1.2) 92 3.2 (0.8) X
2
 (3, N = 53)  
= 16.80,             
p =.010 
F (3,52) = 2.80,  
p =.049 
Anxiety 
64 1.7 (1.1) 68 2.6 (0.9) 83 2.6 (1.2) 92 3.1 (0.7) X
2
 (3, N = 53) 
= 6.08, 
p=.108 
F (3,52) = 4.26, 
p =.009 
 
Preoccupation 
with illness 
71 1.7 (1.1) 74 2.9 (1.2) 83 2.3 (1.4) 92 2.9 (0.8) X
2
 (3, N = 53) 
= 5.39, 
p=.145 
F (3,52) = 3.34,  
p =.026 
Embarrassment 
50 1.5 (1.3) 58 2.2 (0.9) 42 1.5 (1.2) 62 2.6 (1.2) X
2
 (3, N = 53) 
= 3.51, 
p=.320 
F (3,51) = 2.91, 
p =.043 
 
Fear of 
recurrence 
79 2.4 (1.2) 79 3.3 (0.8) 92 2.8 (1.3) 85 3.4 (0.7) X
2
 (3, N = 52) 
= 5.89, 
p=.117 
F (3,52) = 2.40, 
p=.078 
 
 
 
 
 
 
 
 
Worry about 
what the 
future holds 
86 2.3 (1.1) 68 2.8 (0.9) 83 2.8 (1.2) 92 3.3 (0.9) X
2
 (3, N = 53) 
= 2.06, 
p=.561 
F (3,52) = 2.02, 
p=.123 
 
Worry about 
dying 
64 2.1 (1.6) 63  2.7 (1.2) 75 2.3 (1.2) 92 3.3 (0.8) X
2
 (3, N = 52) 
= 5.78, 
p=.123 
F (3,51) = 1.94, 
p=.135 
 
Shock of 
diagnosis 
86 3.0 (1.5) 68 3.4 (0.5) 83 3.2 (0.9) 92 3.8 (0.4) X
2
 (3, N = 52) 
= 2.41, 
p=.491 
F (3,50) = 1.82, 
p=.155 
 
Anger 
64 1.9 (1.5) 74 2.7 (1.1) 58 2.2 (1.2) 69 2.4 (1.0) X
2
 (3, N = 53) 
= 5.08, 
p=.166 
F (3,52) = 1.32, 
p=.277 
 
Question why 
is this 
happening to 
me? 
79 2.6 (1.3) 68 2.9 (1.1) 58 1.8 (1.0) 85 3.2 (0.8) X
2
 (3, N = 52) 
= 6.17, 
p=.104 
F (3,51) = 3.32, 
p =.027 
 
Feel let down 
by your body 
64 2.0 (1.3) 37 2.1 (1.3) 42 1.8 (1.3) 62 2.5 (1.3) X
2
 (3, N = 51) 
= 1.96, 
p=.580 
F (3,50) = 0.47, 
p=.706 
 
Body image 
Altered 
appearance 
79 2.9 (1.4) 68 2.7 (1.2) 75 2.4 (1.3) 69 3.1 (0.8) X
2
 (3, N = 53) 
= 7.69, 
p=.857 
F (3,52) = 0.64, 
p=.590 
 
More self-
conscious and 
concern about 
one’s 
appearance 
79 2.6 (1.4) 68 2.2 (0.9) 67 2.1 (1.2) 46 2.0 (1.1) X
2
 (3, N = 53) 
= 4.92, 
p=.178 
F (3,52) = 0.62, 
p=.606 
 
 
 
 
 
 
 
Less concerned 
about one’s 
appearance 
50 1.4 (1.2) 53 1.8 (1.1) 25 1.3 (0.9) 62 1.64 (0.8) X
2
 (3, N = 52) 
= 6.64, 
p=.084 
F (3,52) = 0.87, 
p=.464 
 
Self-
appraisals 
Greater self-
awareness 
86 2.3 (1.4) 47 2.2 (1.7) 75 2.5 (1.0) 54 2.0 (0.8) X
2
 (3, N = 51) 
= 2.17, 
p=.537 
F (3,51) = 0.42, 
p=.739 
 
Stronger 
person 
93 2.6 (0.9) 53 2.4 (1.0) 75 2.2 (1.1) 62 2.4 (0.8) X
2
 (3, N = 51) 
= 2.42, 
p=.489 
F (3,51) = 0.53, 
p=.661 
 
Better person 
71 2.0 (1.1) 42 2.1 (1.0) 33 1.4 (1.1) 15 1.4 (0.7) 
X
2
 (3, N = 51) 
= 8.45,           
p =.037 
 
F (3,50) = 1.84, 
p=.151 
 
 
Braver 
64 2.2 (1.4) 53 2.2 (0.9) 42 1.8 (1.1) 54 2.0 (1.1) X
2
 (3, N = 51) 
= 2.62, 
p=.455 
F (3,50) = 0.48, 
p=.700 
 
Increased 
maturity 
86 3.2 (1.0) 68 2.8 (0.7) 25 1.4 (1.2) 0 1.0 (0.0) 
X
2
 (3, N = 51) 
= 31.24,         
p =<.001 
 
F (3,49) = 
17.13,  
p=<.001 
Greater 
confidence 
50 1.7 (1.4) 37 1.7 (1.0) 42 1.5 (1.3) 23 1.3 (0.5) X
2
 (3, N = 50) 
= 1.99, 
p=.574 
F (3,49) = 0.36, 
p=.784 
 
 
 
 
 
 
 
 
Lowered self-
confidence / 
self-esteem 
71 1.9 (1.1) 58 2.1 (1.2) 58 1.9 (1.2) 69 2.5 (1.0) X
2
 (3, N = 51) 
= 1.96, 
p=.582 
F (3,51) = 0.65, 
p=.587 
 
Outlook on 
life 
Changed 
outlook on life 
86 2.5 (1.2) 74 3.2 (0.6) 75 2.4 (1.0) 77 2.9 (1.0) X
2
 (3, N = 51) 
= 4.05, 
p=.256 
F (3,51) = 2.42, 
p=.077 
 
More positive 
outlook on life 
71 2.5 (1.3) 47 2.1 (1.1) 46 1.8 (1.3) 31 1.8 (1.2) X
2
 (3, N = 51) 
= 7.31, 
p=.293 
F (3,50) = 0.79, 
p=.506 
 
Different 
priorities in life 
100 3.1 (0.9) 79 3.1 (0.9) 88 2.3 (1.4) 85 3.3 (0.7) X
2
 (3, N = 52) 
= 6.93 , 
p=.327 
F (3,50) = 2.36, 
p=.082 
 
Greater desire 
to live life to 
the fullest 
93 3.0 (1.0) 68 2.9 (1.0) 83 2.5 (1.4) 62 2.4 (1.0) X
2
 (3, N = 51) 
= 2.82, 
p=.421 
F (3,50) = 0.87, 
p=.463 
 
Greater life 
experience 
79 2.8 (1.2) 63 2.1 (0.8) 67 2.3 (1.2) 62 2.3 (1.0) X
2
 (3, N = 51) 
= 1.43, 
p=.699 
F (3,50) = 1.18, 
p=.325 
 
Greater 
awareness of 
one’s mortality 
71 2.5 (1.3) 47 2.1 (1.3) 75 2.5 (1.2) 62 2.7 (1.3) X
2
 (3, N = 51) 
= 1.43, 
p=.699 
F (3,50) = 0.59, 
p=.623 
 
 
 
Inability to 
plan for the 
future 
57 2.2 (1.3) 63 2.3 (1.1) 50 2.1 (1.4) 85 3.3 (0.8) 
X
2
 (3, N = 51) 
= 10.11,         
F (3,50) = 2.56, 
p=.066 
 
 
 
 
 
 
 
 
p =.018 
Greater 
motivation to 
succeed 
academically 
86 2.8 (1.2) 42 2.0 (1.1) 25 1.3 (1.1) 8 1.2 (0.6) X
2
 (3, N = 51) 
= 17.68, 
p<.001 
 
F (3,49) = 6.18,   
p=<.001 
 
Greater 
motivation to 
achieve 
personal goals 
79 2.6 (1.4) 53 2.4 (1.2) 42 1.8 (1.4) 38 1.7 (0.8) X
2
 (3, N = 52) 
2.43= , 
p=.142 
F (3,51) = 1.87, 
p=.146  
 
Lifestyle 
Motivation to 
lead a healthier 
lifestyle 
79 2.3 (1.2) 68 2.6 (1.1) 75 2.4 (1.0) 85 2.5 (1.1) X
2
 (3, N = 52) 
= 2.43, 
p.=.049 
F (3,52) = 0.30, 
p=.824  
 
Take greater 
care to avoid 
infections 
100 3.2 (0.8) 63 2.7 (0.9) 67 1.8 (1.2) 69 2.2 (1.1) X
2
 (3, N = 53) 
= 5.20 , 
p=.157 
F (3,52) = 4.89,  
p =.005 
Difficulty 
adjusting to 
being ill and 
having to take 
medication 
64 2.0 (1.5) 68 2.6 (1.2) 75 2.3 (1.2) 69 2.5 (0.9) X
2
 (3, N = 51) 
= 2.54, 
p=.468 
F (3,52) = 0.78, 
p=.513 
 
Restricted food 
choice 
79 2.6 (1.2) 42 2.1 (1.2) 58 1.8 (1.4) 62 2.5 (1.4) X
2
 (3, N = 53) 
= 2.24, 
p=.524 
F (3,52) = 0.97, 
p=.415 
 
Restricted 
choice of drinks 
64 2.2 (1.3) 42 2.2 (1.3) 58 1.7 (1.2) 62 2.4 (1.2) X
2
 (3, N = 53) 
= 0.62 , 
p=.892 
F (3,52) = 0.69, 
p=.563  
 
 
 
 
 
 
 
 
Treatment-
related 
Dissatisfaction 
with care 
43 1.3 (1.2) 63 2.3 (1.2) 58 1.8 (1.3) 77 2.5 (1.1) X
2
 (3, N = 53) 
= 6.58, 
p=.087 
F (3,51) = 2.76, 
p=.052 
 
Lack of age 
appropriate 
information  
50 1.6 (1.4) 42 1.9 (1.3) 33 1.3 (0.8) 8 1.2 (0.4) X
2
 (3, N = 52) 
=6.81 , 
p=.078 
F (3,52) = 1.50, 
p=.224  
 
Treatment 
burden 
79 2.5 (0.9) 68 3.0 (1.2) 67 2.9 (1.0) 85 3.3 (0.9) X
2
 (3, N = 50) 
= 0.65, 
p=.886 
F (3,51) = 1.37, 
p=.263 
 
Life beyond 
treatment 
Difficulty 
readjusting to 
life after 
treatment is 
over 
71 2.3 (1.3) 53 2.4 (1.4) 50 2.1 (1.3) 69 2.6 (1.1) X
2
 (3, N = 49) 
= 2.31, 
p=.511 
F (3,51) = 0.28, 
p=.841  
 
Concern over 
long-term 
effects of 
disease or 
treatment 
79 2.3 (1.1) 74 3.2 (0.9) 75 2.6 (1.4) 92 3.7 (0.5) X
2
 (3, N = 52) 
= 6.86, 
p=.076 
F (3,50) = 4.86,  
p =.005 
Concerns over 
fertility 
71 2.1 (1.4) 68 3.3 (0.9) 50 1.9 (1.6) 8 1.1 (0.3) X
2
 (3, N = 52) 
= 20.44           
p =<.001 
 
F (3,49) = 8.62, 
p =<.001 
 
Desire for life 
to return to 
“normal” 
93 3.6 (0.9) 63 3.2 (1.4) 100 3.3 (1.1) 92 3.6 (0.7) X
2
 (3, N = 52) 
= 3.39, 
p=.336 
F (3,50) = 0.61, 
p=.613 
 
Financial 
difficulties 
36 1.2 (1.1) 58 2.7 (1.2) 75 2.3 (1.4) 77 3.0 (1.4) X
2
 (3, N = 52) 
= 8.88,           
p =.031 
F (3,49) = 5.08,  
p =.004 
 
 
 
 
 
 
 
 
